Roche Releases More Evrysdi Data For Very Young Infants With SMA - Benzinga

Retrieved on: 2022-04-30 07:09:03

Tags for this article:

Click the tags to see associated articles and topics

Roche Releases More Evrysdi Data For Very Young Infants With SMA - Benzinga. View article details on hiswai:

Excerpt

Roche Holding AG's RHHBY Genentech has released new long-term data on its oral drug for spinal muscular atrophy (SMA).

Article found on: www.benzinga.com